Opendata, web and dolomites

NEOCANTAL

New Oleocanthal-based functional ingredients with anti-inflamatory properties obtained from olive pomace valorisation

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 NEOCANTAL project word cloud

Explore the words cloud of the NEOCANTAL project. It provides you a very rough idea of what is the project "NEOCANTAL" about.

people    ingenier    phenols    recognised    stable    opportunity    diet    oleocanthal    identification    ibuprofen    neocantal    liquid    trial    sole    industries    points    nutrition    agronomic    obtain    natural    feasibility    producers    treatment    pursposes    valuable    packaging    agro    demonstrated    cosmetics    pain    patients    circular    material    compounds    extra    cruz    follow    harmful    raw    customers    virgin    care    patent    olive    times    mediterranean    varieties    diverse    op    tackle    last    17    industrial    pure    evoo    turnover    15m    anti    added    cumulative    food    ingredients    exist    iacute    santa    wellbeing    economic    firm    clinical    engineering    environmentally    viability    industry    encapsulated    healthy    decades    pollutant    specialised    spanish    pomace    diseases    drugs    dramatically    oil    concentration    powder    functional    commercial    nonsteroidal    relationship    70    deepen    economy    intake    turn    extracts    differentiate    inflammatory    cid    pharma    chronic    forms    mitigate    launching    health   

Project "NEOCANTAL" data sheet

The following table provides information about the project.

Coordinator
SANTA CRUZ INGENIERIA SL 

Organization address
address: AVDA.EDUARDO DATO NUM 45 ESC 1 PLANTA B
city: SEVILLA
postcode: 41018
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website https://www.santacruzingenieria.com/proyectos-de-id/neocantal/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-02-01   to  2019-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SANTA CRUZ INGENIERIA SL ES (SEVILLA) coordinator 50˙000.00

Map

 Project objective

Chronic inflammatory diseases (CID) have dramatically risen in the last decades. Current sole treatment for patients is the long-term intake of nonsteroidal anti-inflammatory drugs with associated harmful side effects, such as ibuprofen, to mitigate their pain. Research has demonstrated that there exist a strong relationship between nutrition and chronic diseases. This way, the extra virgin olive oil’s (EVOO) health effects have been assessed through diverse studies focusing on the Mediterranean diet. Researchers have recognised natural anti-inflammatory properties to oleocanthal, one of the phenols compounds present in the EVOO. Concentration of oleocanthal is 100 times higher in the olive pomace (OP), a highly pollutant by-product from the olive oil industry. Santa Cruz Ingeniería is an agro-industrial engineering firm specialised in agronomic management and R&D. During last years, we have focused on the identification of oleocanthal-rich olive varieties and on the process to obtain stable oleocanthal extracts (Spanish patent application under study). NEOCANTAL is a great Circular Economy opportunity (cumulative turnover of €17.15M three years after its launching) to turn the environmentally harmful and low-cost OP into a valuable raw material for new oleocanthal-rich (60-70% pure) functional ingredients with anti-inflammatory pursposes. It will be produced in three different forms to be added to a wide range of food products: OP powder, liquid and encapsulated oleocanthal. Our target customers are food producers willing to differentiate their products as functional, while our end-users are CID’s patients, but also people who care of their wellbeing or follow healthy trends. In the future, we will address the cosmetics, food packaging and pharma industries. This Feasibility Study’s goal is to deepen in those key points to assess the economic, technical and commercial viability of NEOCANTAL (including a clinical trial) to tackle this challenge for us to scale-up.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NEOCANTAL" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NEOCANTAL" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

DetectInMen (2019)

Infection detection in human semen

Read More  

ECOBIOMASS (2019)

Achieving unique wines through an efficient production process

Read More  

ALR4000 (2019)

Automated LCD Recycling series 4000

Read More